openPR Logo
Press release

United States Neurovascular Embolization Devices Market Opportunities, Challenges, and Growth Forecast by 2024-2031 - Medtronic plc, Stryker Corporation, Johnson & Johnson Inc.

09-23-2025 11:52 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Neurovascular Embolization Devices Market

Neurovascular Embolization Devices Market

Global Neurovascular Embolization Devices Market reached US$ 3.7 billion in 2022 and is expected to reach US$ 6.0 billion by 2031, growing with a CAGR of 6.4% during the forecast period 2024-2031.

Neurovascular embolization devices are minimally invasive tools used to treat conditions like aneurysms, arteriovenous malformations (AVMs), and tumors. They include coils, stents, and liquid embolics to block abnormal blood flow or reinforce weak vessel walls. These devices reduce the risks of rupture and bleeding, providing a safer alternative to open surgery. Advances in materials and designs have improved their efficacy and precision. They are integral in modern neurovascular interventions.

๐Ÿ“Œ Download Sample Report to Identify Emerging Deals & Opportunities in the Neurovascular Embolization Devices Market Landscape:- https://datamintelligence.com/download-sample/neurovascular-embolization-devices-market?rk

โ˜› Neurovascular Embolization Devices Market Recent Developments 2025:

United States: Recent Industry Developments

โœ… In July 2025, the U.S. neurovascular embolization devices market was valued at approximately USD 1.32 billion and is projected to reach USD 1.38 billion by 2025, reflecting a 4.8% annual growth rate.

โœ… In January 2025, the global aneurysm coiling and embolization devices market was estimated to grow by USD 2.0 billion from 2025 to 2029, driven by rising cases of intracranial aneurysms and advancements in AI-powered treatment technologies.

โœ… In May 2025, iVascular and Medico's Hirata received regulatory approval from Japan's Ministry of Health, Labour, and Welfare for the Luminor 18 RX drug-coated balloon, tailored for Japanese clinical practices.

Japan: Recent Industry Developments

โœ… In September 2025, the neurovascular embolization devices market in Japan was valued at approximately USD 1.12 billion and is anticipated to reach USD 1.75 billion by 2032, with a projected CAGR of 6.6%.

โœ… In May 2025, iVascular and Medico's Hirata launched the Luminor 18 RX drug-coated balloon in Japan, a rapid-exchange device optimized for local clinical practices.

โœ… In November 2024, Medtronic was identified as the leading neurovascular embolization devices manufacturer in Japan for 2023.

โ˜› Neurovascular Embolization Devices Market Competitve Landscape:

Medtronic plc, Stryker Corporation, Johnson & Johnson Inc., Terumo Corporation, B. Braun Melsungen AG., Integra LifeSciences Corporation, Acandis GmBH, Phenox GmBH, Lepu Medical Technology (Beijing)Co., and Shape Memory Medical Inc.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

๐Ÿ“Œ Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/neurovascular-embolization-devices-market

โ˜› Segment Covered in the Neurovascular Embolization Devices Market:

By Product Type: Liquid Embolic Systems, Embolization Coils, Aneurysm Clips, Flow Diversion Stents, Others.

By Treatment: Ischemic Stroke Solutions, Hemorrhagic Stroke Solutions, Indication, Brain aneurysm, Arteriovenous malformations, Others.

By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic Research Centers, Others.

โ˜› This Report Includes:

โœ” Comprehensive go-to-market strategies with actionable insights.

โœ” Unbiased evaluation of overall market performance.

โœ” Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

โœ” Tailored regional and country-level reports with detailed localized analysis available on request.

โœ” Identification of niche segments and high-growth regions presenting strong opportunities.

โœ” Accurate regional forecasts using both top-down and bottom-up approaches.

๐Ÿ“Œ Get Corporate Access to Live Neurovascular Embolization Devices Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=neurovascular-embolization-devices-market

โ˜› Regional Analysis for Neurovascular Embolization Devices Market:

โ‡ฅ North America (U.S., Canada, Mexico)

โ‡ฅ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

โ‡ฅ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

โ‡ฅ South America (Colombia, Brazil, Argentina, Rest of South America)

โ‡ฅ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

โ˜› Frequently asked questions:

โž  What is the global sales, production, consumption, import, and export value of the Neurovascular Embolization Devices Market?
โž  Who are the key global manufacturers, and what is their operational performance?
โž  What are the major opportunities and threats in the global Neurovascular Embolization Devices Market?
โž  Which product types or end-users show the most growth potential and market share?
โž  What challenges and constraints are impacting the Neurovascular Embolization Devices Market?
โž  What sales, marketing, and distribution channels are used globally?

๐Ÿ“Œ Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

โ˜› Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

โœ… Competitive Landscape
โœ… Sustainability Impact Analysis
โœ… KOL / Stakeholder Insights
โœ… Unmet Needs & Positioning, Pricing & Market Access Snapshots
โœ… Market Volatility & Emerging Risks Analysis
โœ… Quarterly Industry Report Updated
โœ… Live Market & Pricing Trends
โœ… Import-Export Data Monitoring

โ˜› Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Neurovascular Embolization Devices Market Opportunities, Challenges, and Growth Forecast by 2024-2031 - Medtronic plc, Stryker Corporation, Johnson & Johnson Inc. here

News-ID: 4193821 • Views: โ€ฆ

More Releases from DataM Intelligence 4market Research LLP

United States Feed Testing Market Booms on 6.50% CAGR - North America Dominates 35% Share Amid Rising FDA Compliance & Livestock Safety Demands
United States Feed Testing Market Booms on 6.50% CAGR - North America Dominates โ€ฆ
According to DataM Intelligence, the global feed testing market size was valued at US$3.50 billion in 2024 and is forecasted to reach US$5.70 billion by 2031, growing at a CAGR of 6.50% during the forecast period (2024-2031). This steady growth is propelled by stringent regulatory standards for animal feed safety, rising demand for high-quality meat and dairy products, increasing livestock production, growing pet food safety concerns, and expanding focus onโ€ฆ
United States Sugar Decorations & Inclusions Market Surges on 5.80% CAGR - Customizable Desserts & Bakery Personalization Fuel North America's 38% Revenue Dominance
United States Sugar Decorations & Inclusions Market Surges on 5.80% CAGR - Custo โ€ฆ
According to DataM Intelligence, the global sugar decorations and inclusions market size was valued at US$2.15 billion in 2023 and is forecasted to reach US$3.45 billion by 2030, growing at a CAGR of 5.80% from 2023 to 2030. This steady growth is propelled by rising demand for personalized baked goods, expanding bakery and confectionery sectors, increasing consumer preference for visually appealing desserts, growth in organized retail for convenience foods, andโ€ฆ
Aluminum Extrusion Industry Forecast 2025-2031: Rising Demand in Automotive and Construction Sectors | Top Companies are Arconic Corporation, Bahrain Aluminum Extrusion Co. (BALEXCO), Century Extrusions Ltd
Aluminum Extrusion Industry Forecast 2025-2031: Rising Demand in Automotive and โ€ฆ
Global Aluminum Extrusion Market reached US$ 78.7 billion in 2022 and is expected to reach US$ 117.8 billion by 2030, growing with a CAGR of 5.7% during the forecast period 2025-2031. According to DataM Intelligence has published a new research report on "Aluminium Extrusion Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players andโ€ฆ
United States Cellulose Gel Market Poised for 7.12% CAGR Through 2031 Driven by Pharma, Food & Clean-Label Demand
United States Cellulose Gel Market Poised for 7.12% CAGR Through 2031 Driven by โ€ฆ
The global cellulose gel market is projected to reach at a CAGR of 7.12% from 2024 to 2031., according to DataM Intelligence. United States: Recent Industry Developments โœ… In October 2025, Cargill Inc. launched a new line of clean-label food-grade cellulose gel derived from sustainable U.S. cotton sources, optimized for low-calorie bakery stabilizers amid rising demand for processed foods. โœ… In September 2025, DuPont de Nemours expanded its pharmaceutical-grade cellulose gel production inโ€ฆ

All 5 Releases


More Releases for Neurovascular

Emerging Trends Influencing The Growth Of The Neurovascular Catheters Market:Inn โ€ฆ
The Neurovascular Catheters Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Neurovascular Catheters Market Size Expected to Be by 2034? The Neurovascular Catheters Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.โ€ฆ
Top Factor Driving Neurovascular Embolization Devices Market Growth in 2025: Ris โ€ฆ
What combination of drivers is leading to accelerated growth in the neurovascular embolization devices market? The rise in the prevalence of hemorrhages is expected to drive the neurovascular embolization devices market. Hemorrhages, caused by factors such as hypertension and anticoagulant medications, are treated using neurovascular embolization devices, which block abnormal blood vessels to reduce bleeding and prevent further brain damage. In February 2024, research by King's College London indicated a projectedโ€ฆ
Exploring the Neurovascular Catheters Market: Innovative Approaches to Neurovasc โ€ฆ
Allied Market Research Analyst have added a new research study on Title Neurovascular Catheters Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as Zeus Industrial Products, Stryker, Biomerics, Integra Life Sciences, Concentric Medical, DePuy Synthes, Medtronic, RAUMEDIC, Johnson and Johnson, Integer Holdings Corporation. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies and plans. The facts andโ€ฆ
Neurovascular Devices industry expected to hit a valuation of US$ 7 billion till โ€ฆ
The global ๐๐ž๐ฎ๐ซ๐จ๐ฏ๐š๐ฌ๐œ๐ฎ๐ฅ๐š๐ซ ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ market is estimated to attain a valuation of US$ 7 Bn by the end of 2033, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 7.6% during the forecast period, 2023 - 2033. The key objective of the TMR report is to offer a complete assessment of the global market including major leadingโ€ฆ
Brain Aneurysm Treatment - Modern Neurovascular Techniques
Brain aneurysm is a development of bulge in brain vessels. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which can cause death of the patient. Get PDF Brochure of Research Study @ https://bit.ly/2zir2hL Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm. The global brain aneurysm treatment marketโ€ฆ
Neurovascular Devices Market: Opportunities and Challenges
The Neurovascular Devices Market is expected to reach USD 2.62 billion by 2021 from USD 1.74 billion in 2016, at a CAGR of 8.6% from 2016 to 2021. Increasing research activities in the field of neurovascular therapies Neurovascular devices are witnessing a growing demand among the major stakeholders globally, due to increasing clinical research activities in the field of neurovascular therapies, which offer credible clinical data related to their safety & efficacyโ€ฆ